Postpartum choriocarcinoma: Presentation, management and survival

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 51, Issue 10, 2006, Pages 819-824

  Nugent, David ^a   Hassadia, Ayman ^a   Everard, Jan ^a   Hancock, Barry W ^a   Tidy, John A ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Choriocarcinoma; Gestational trophoblastic neoplasms; Postpartum period

Indexed keywords

DACTINOMYCIN; ETOPOSIDE; METHOTREXATE;

ADULT; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER SURVIVAL; CHORIOCARCINOMA; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; DELAYED DIAGNOSIS; DRUG RESPONSE; FEMALE; HIGH RISK PATIENT; HUMAN; INTERNATIONAL FEDERATION OF GYNECOLOGY AND OBSTETRICS SCORE; MEDICAL RECORD; METASTASIS; MONOTHERAPY; OUTCOME ASSESSMENT; POSTPARTUM CHORIOCARCINOMA; PRIORITY JOURNAL; PUERPERAL DISORDER; SCORING SYSTEM; SYMPTOM; TROPHOBLASTIC TUMOR; UNITED KINGDOM; VAGINA BLEEDING;

ADULT; CHORIOCARCINOMA; ENGLAND; FEMALE; HUMANS; MEDICAL RECORDS; NEOPLASM METASTASIS; PREGNANCY; PUERPERAL DISORDERS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; UTERINE NEOPLASMS;

EID: 33750214682     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (12)

1. Bagshawe KD, Dent J, Webb J: Hydatidiform mole in England and Wales in 1973-1983. Lancet 1986;1:673-677
2. Bagshawe KD: Risk and prognostic factors in trophoblastic neoplasia. Cancer 1976;38:1371-1385
3. Tidy JA, Rustin GJS, Newlands ES, et al: Presentation and management of choriocarcinoma after nonmolar pregnancy. Br J Obstet Gynaecol 1995;102:715-719
4. Bower M, Newlands ES, Holden L, et al: EMA/CO for high-risk gestational trophoblastic tumors: Results from a cohort of 272 patients. J Clin Oncol 1997;15:2636-2643
5. Dobson LS, Gillespie AM, Coleman RE, et al: The presentation and management of post-partum choriocarcinoma. Br J Cancer 1999;79:1531-1533
6. Hancock BW: Differences in management and treatment: A critical appraisal. In Gestational Trophoblastic Disease. Second edition. Edited by BW Hancock, ES Newlands, RS Berkowitz, et al. www.isstd.org/gtd/contents, 2003, pp 337-347
7. Hoveyda F, Mackenzie IZ: Secondary postpartum haemorrhage: Incidence, morbidity and current management. Br J Obstet Gynaecol 2001;108:927-930
8. Heath V, Chadwick V, Cooke I, et al: Should tissue from pregnancy termination and uterine evacuation routinely be examined historically? Br J Obstet Gynaecol 2000;107:727-730
9. Royal College of Obstetricians and Gynecologists: The Management of Gestational Trophoblastic Neoplasia. London, RCOG Press, 2004
10. Bagshawe KD, Dent J, Newlands ES, et al: The role of low dose methotrexate and folinic acid in gestational trophoblastic tumours. Br J Obstet Gynaecol 1989;96:795-802
11. Crawford RAF, Newlands E, Rustin CJS, et al: Cestational trophoblastic disease with liver metastases: The Charing Cross experience. Br J Obstet Gynaecol 1997;104:105-109
12. Kohorn EI: The FIGO 2000 staging and risk factor scoring system for gestational trophoblastic neoplasia. In Gestational Trophoblastic Disease. Second edition. Edited by BW Hancock, ES Newlands, RS Berkowitz, et al. www.isstd.org/gtd/contents, 2003, pp 175-181